PRISM MediaWire

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, FLORIDA, December 13, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

13 December 2023

PRISM Next Gen Tech Company Spotlight: The Glimpse Group’s Journey into the Future

NEW YORK, NY, December 07, 2023 - PRISM MediaWire - In the ever-evolving landscape of technological innovation, the Glimpse Group, Inc. (VRAR) emerges as a beacon of creativity and ingenuity, weaving a future where virtual and augmented realities seamlessly blend with ou...

7 December 2023

PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA)

NEW YORK, NY, December 07, 2023 - PRISM MediaWire -PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global biopharmaceutical company with a portfolio of products for rare and serio...

7 December 2023

SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone

Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi ...

27 November 2023

EASY ENERGY SYSTEMS TO EXHIBIT AT ORGANIC GROWERS SUMMIT IN MONTEREY, CA

Mankato, Minnesota, November 21, 2023 - Digital Utilities Ventures, Inc. (OTC: DUTV), announces that its planned future affiliate, Easy Energy Systems, Inc., will be exhibiting at the Organic Growers Show in Monterey on November 29-30. The summit provides growers firsth...

21 November 2023

PRISM MediaWire - Weekly Press Resume - Nov. 13 to Nov. 17, 2023

PRISM MediaWire

17 November 2023

BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

Company to Host a Conference Call and Webcast on November 14, 2023, at 10:30 am EDT

14 November 2023

Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug

“GvHD affects approximately 30,000 Americans and oral GvHD causes significant oral pain and discomfort, making it difficult for patients to eat, drink and speak. Oral GvHD is a great unmet need in cancer survivors.” ~Dr. Michael Chancellor, Chief Medical Officer at Lipel...

10 November 2023

BioStem Technologies Awarded Q Code for VENDAJE AC®

“Securing the CMS Q code for our VENDAJE AC® tissue allograft marks yet another win for BioStem Technologies and ensures broader access to another top-tier wound care product within our portfolio.” ~BioStem Technologies CEO, Jason Matuszewski

8 November 2023

BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

POMPANO BEACH, FLORIDA, November 8, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announ...

8 November 2023